이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

CXI Healthcare Technology Group 대차 대조표 상태

재무 상태 기준 확인 6/6

CXI Healthcare Technology Group 의 총 주주 지분은 ₩448.1B 이고 총 부채는 ₩0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 ₩450.8B 및 ₩2.7B 입니다. CXI Healthcare Technology Group 의 EBIT는 ₩16.6B 이며 이자보상배율은 -75.3 입니다. ₩149.0B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

부채 비율

₩0

부채

이자 보상 비율	-75.3x
현금	₩148.99b
주식	₩448.05b
총 부채	₩2.72b
총 자산	₩450.78b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Lacklustre Performance Is Driving CXI Healthcare Technology Group Limited's (KOSDAQ:900120) Low P/S

May 30

How Much Did CKH Food & Health's(KOSDAQ:900120) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 02

재무 상태 분석

단기부채: A900120 의 단기 자산 ( ₩163.1B )이 단기 부채( ₩2.6B ).

장기 부채: A900120 의 단기 자산( ₩163.1B )이 장기 부채( ₩99.9M ).

부채 대 자본 내역 및 분석

부채 수준: A900120 부채가 없습니다.

부채 감소: A900120 는) 부채 대 자기자본 비율이 0.3% 였던 5년 전과 비교하여 부채가 없습니다.

부채 범위: A900120 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: A900120 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

CXI Healthcare Technology Group 대차 대조표 상태

재무 상태 기준 확인 6/6

주요 정보

최근 재무 상태 업데이트

Recent updates

Lacklustre Performance Is Driving CXI Healthcare Technology Group Limited's (KOSDAQ:900120) Low P/S

Investor sentiment improves as stock rises 28%

New major risk - Shareholder dilution

First quarter 2024 earnings released: EPS: ₩34.00 (vs ₩16.00 in 1Q 2023)

CKH Food & Health Limited announced that it has received KRW 7.432995165 billion in funding

New minor risk - Share price stability

Investor sentiment improves as stock rises 35%

Investor sentiment deteriorates as stock falls 16%

New major risk - Shareholder dilution

Third quarter 2023 earnings released: ₩6.00 loss per share (vs ₩7.00 profit in 3Q 2022)

Second quarter 2023 earnings released: ₩41.00 loss per share (vs ₩2.00 loss in 2Q 2022)

CKH Food & Health Limited has completed a Follow-on Equity Offering in the amount of KRW 999.99999 million.

First quarter 2023 earnings released: EPS: ₩16.00 (vs ₩11.00 loss in 1Q 2022)

No independent directors

Investor sentiment improved over the past week

CKH Food & Health Limited announced that it has received KRW 10.911791808 billion in funding from Rui Xing International Holdings Limited

CKH Food & Health Limited announced that it expects to receive KRW 10.911791808 billion in funding from Rui Xing International Holdings Limited, and other investors

Third quarter 2022 earnings released: EPS: ₩7.00 (vs ₩9.00 loss in 3Q 2021)

No independent directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment deteriorated over the past week

CKH Food & Health Limited has completed a Follow-on Equity Offering in the amount of KRW 999.99981 million.

Third quarter 2021 earnings released: ₩9.00 loss per share (vs ₩139 loss in 3Q 2020)

CKH Food & Health Limited announced that it has received KRW 2.270259148 billion in funding

CKH Food & Health Limited announced that it expects to receive KRW 2.270259148 billion in funding

CKH Food & Health Limited announced that it has received KRW 679.08 million in funding

CKH Food & Health Limited announced that it expects to receive KRW 679.08 million in funding

Second quarter 2021 earnings released: ₩17.00 loss per share (vs ₩133 loss in 2Q 2020)

New 90-day low: ₩405

First quarter 2021 earnings released: EPS ₩10.00

How Much Did CKH Food & Health's(KOSDAQ:900120) Shareholders Earn From Share Price Movements Over The Last Five Years?

New 90-day high: ₩354

New 90-day high: ₩295

New 90-day high: ₩274

New 90-day low - ₩212

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

건강한 기업 발견하기